IP finance

"Where money issues meet IP rights". This weblog looks at financial issues for intellectual property rights: securitisation and collateral, IP valuation for acquisition and balance sheet purposes, tax and R&D breaks, film and product finance, calculating quantum of damages--anything that happens where IP meets money.

Showing posts with label underpaying. Show all posts
Showing posts with label underpaying. Show all posts
Monday, 26 February 2018

Trump White House Releases Biopharmaceutical Pricing Reform White Paper

›
The White House Council of Economic Advisers recently released a report titled, “Reforming Biopharmaceutical Pricing at Home and Abroad....
›
Home
View web version
Powered by Blogger.